Search results for "Rigaku Analytical Devices"
Selected Filters:
Omega Optical Launches New Website
Bio-Rad introduces anti-evolocumab antibodies for use in preclinical and clinical drug development
Bio-Rad’s growing range of anti-idiotypic antibodies offers researchers enhanced flexibility for the development of custom bioanalytical drug assays
Sartorius completes acquisition of Novasep’s chromatography division
Acquisition enables Sartorius to continue to develop optimized systems for membrane-based chromatography technology
Sartorius strengthens its bioanalytics portfolio
Sartorius acquires a majority stake in ALS Automated Lab Solutions
Seegene unveils fully automated molecular testing system at the 2021 AACC
The new MDx system will efficiently access a wide array of Seegene's syndromic assays
Registration now open for the SelectScience Virtual Clinical Science Summit 2021
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Vote for the Best New Clinical Products in the 2021 Scientists’ Choice Awards
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics
RoosterBio collaborates with Sartorius to expand cell and gene therapy manufacturing platform technology into South Korea
The partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia
Arctoris and Syntekabio form research partnership
PerkinElmer introduces AuroFlow AQ Mycotoxin Platform to support testing for top six regulated mycotoxins in grain commodities
Features water-based testing strips and handheld reader delivering convenience and accuracy
Bio-Rad launches anti-certolizumab pegol antibodies
Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of anti-drug antibody (ADA) assays
Horizon Discovery offers CHOSOURCE platform for COVID-19-related therapeutics and diagnostics
Special licensing terms enable rapid access to CHOSOURCE platform to streamline SARS-CoV-2 therapeutic development and production processes
Abcam acquires gene-editing platform and oncology product portfolio from US biotech Applied StemCell
Transaction adds comprehensive cell editing capabilities and engine to support expansion of Abcam’s existing portfolio of ‘off-the-shelf’ edited cell lines
JIR Secondary Antibodies for the Investigation of Bio-Nanotechnology in Healthcare Delivery
The importance of good secondary antibodies in understanding the effects of drug delivery vehicles